Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA75286
Max Phase: Preclinical
Molecular Formula: C24H34N2O
Molecular Weight: 366.55
Molecule Type: Small molecule
Associated Items:
ID: ALA75286
Max Phase: Preclinical
Molecular Formula: C24H34N2O
Molecular Weight: 366.55
Molecule Type: Small molecule
Associated Items:
Synonyms (1): PB-183
Synonyms from Alternative Forms(1):
Canonical SMILES: COc1cccc2c(CCCN3CCN(C4CCCCC4)CC3)cccc12
Standard InChI: InChI=1S/C24H34N2O/c1-27-24-14-6-12-22-20(8-5-13-23(22)24)9-7-15-25-16-18-26(19-17-25)21-10-3-2-4-11-21/h5-6,8,12-14,21H,2-4,7,9-11,15-19H2,1H3
Standard InChI Key: OAXSBEWCGPXYFN-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 366.55 | Molecular Weight (Monoisotopic): 366.2671 | AlogP: 4.73 | #Rotatable Bonds: 6 |
Polar Surface Area: 15.71 | Molecular Species: BASE | HBA: 3 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 9.07 | CX LogP: 5.13 | CX LogD: 3.46 |
Aromatic Rings: 2 | Heavy Atoms: 27 | QED Weighted: 0.73 | Np Likeness Score: -0.75 |
1. Berardi F, Ferorelli S, Abate C, Colabufo NA, Contino M, Perrone R, Tortorella V.. (2004) 4-(tetralin-1-yl)- and 4-(naphthalen-1-yl)alkyl derivatives of 1-cyclohexylpiperazine as sigma receptor ligands with agonist sigma2 activity., 47 (9): [PMID:15084129] [10.1021/jm031026e] |
2. Colabufo NA, Abate C, Contino M, Inglese C, Niso M, Berardi F, Perrone R.. (2008) PB183, a sigma receptor ligand, as a potential PET probe for the imaging of prostate adenocarcinoma., 18 (6): [PMID:18276137] [10.1016/j.bmcl.2008.01.109] |
3. Mach RH, Zeng C, Hawkins WG.. (2013) The σ2 receptor: a novel protein for the imaging and treatment of cancer., 56 (18): [PMID:23734634] [10.1021/jm301545c] |
Source(1):